WallStSmart

Barrick Mining Corporation (B)vsSanofi ADR (SNY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Sanofi ADR generates 179% more annual revenue ($47.35B vs $16.96B). B leads profitability with a 29.4% profit margin vs 16.0%. B appears more attractively valued with a PEG of 2.04. B earns a higher WallStSmart Score of 78/100 (B+).

B

Strong Buy

78

out of 100

Grade: B+

Growth: 9.3Profit: 9.0Value: 7.3Quality: 8.5
Piotroski: 7/9Altman Z: 2.38

SNY

Buy

51

out of 100

Grade: C-

Growth: 4.0Profit: 6.5Value: 5.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BUndervalued (+84.9%)

Margin of Safety

+84.9%

Fair Value

$316.39

Current Price

$43.13

$273.26 discount

UndervaluedFair: $316.39Overvalued
SNYUndervalued (+25.0%)

Margin of Safety

+25.0%

Fair Value

$62.70

Current Price

$43.31

$19.39 discount

UndervaluedFair: $62.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

B6 strengths · Avg: 9.5/10
Operating MarginProfitability
52.6%10/10

Strong operational efficiency at 52.6%

Revenue GrowthGrowth
64.5%10/10

Revenue surging 64.5% year-over-year

EPS GrowthGrowth
150.0%10/10

Earnings expanding 150.0% YoY

Market CapQuality
$70.27B9/10

Large-cap with strong market position

Return on EquityProfitability
20.7%9/10

Every $100 of equity generates 21 in profit

Profit MarginProfitability
29.4%9/10

Keeps 29 of every $100 in revenue as profit

SNY4 strengths · Avg: 8.8/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Market CapQuality
$103.45B9/10

Large-cap with strong market position

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$1.68B8/10

Generating 1.7B in free cash flow

Areas to Watch

B1 concerns · Avg: 4.0/10
PEG RatioValuation
2.044/10

Expensive relative to growth rate

SNY3 concerns · Avg: 2.3/10
Return on EquityProfitability
6.6%3/10

ROE of 6.6% — below average capital efficiency

PEG RatioValuation
3.762/10

Expensive relative to growth rate

EPS GrowthGrowth
-11.7%2/10

Earnings declined 11.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : B

The strongest argument for B centers on Operating Margin, Revenue Growth, EPS Growth. Profitability is solid with margins at 29.4% and operating margin at 52.6%. Revenue growth of 64.5% demonstrates continued momentum.

Bull Case : SNY

The strongest argument for SNY centers on Price/Book, Market Cap, Operating Margin. Profitability is solid with margins at 16.0% and operating margin at 20.0%.

Bear Case : B

The primary concerns for B are PEG Ratio.

Bear Case : SNY

The primary concerns for SNY are Return on Equity, PEG Ratio, EPS Growth.

Key Dynamics to Monitor

B profiles as a growth stock while SNY is a mature play — different risk/reward profiles.

B carries more volatility with a beta of 1.07 — expect wider price swings.

B is growing revenue faster at 64.5% — sustainability is the question.

SNY generates stronger free cash flow (1.7B), providing more financial flexibility.

Bottom Line

B scores higher overall (78/100 vs 51/100), backed by strong 29.4% margins and 64.5% revenue growth. SNY offers better value entry with a 25.0% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Barrick Mining Corporation

BASIC MATERIALS · GOLD · USA

Barnes Group Inc. provides engineering products, industrial technologies, and solutions in the United States and internationally. The company is headquartered in Bristol, Connecticut.

Visit Website →

Sanofi ADR

HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA

Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company is headquartered in Paris, France.

Want to dig deeper into these stocks?